Three-dimensional printing in cardiology: Current applications and future challenges by Luo, Hongxing et al.
Address for correspondence: Dr. Hongxing Luo, Department of Cardiology, Zhengzhou University People’s Hospital,  
Zhengzhou, Henan, China, 450003, tel: +86 15290885448, e-mail: 1519782837@qq.com
*Share authorship
Received: 09.12.2016 Accepted: 15.05.2017
Three-dimensional printing in cardiology:  
Current applications and future challenges
Hongxing Luo1*, Jarosław Meyer-Szary2*, Zhongmin Wang1,  
Robert Sabiniewicz2*, Yuhao Liu1*
1Department of Cardiology, Zhengzhou University People’s Hospital  
(Henan Provincial People’s Hospital), Zhengzhou, Henan, China 
2Department of Pediatric Cardiology and Congenital Heart Diseases,  
Medical University of Gdansk, Poland
Abstract
Three-dimensional (3D) printing has attracted a huge interest in recent years. Broadly speaking,  
it refers to the technology which converts a predesigned virtual model to a touchable object. In clinical 
medicine, it usually converts a series of two-dimensional medical images acquired through computed 
tomography, magnetic resonance imaging or 3D echocardiography into a physical model. Medical 3D 
printing consists of three main steps: image acquisition, virtual reconstruction and 3D manufacturing. 
It is a promising tool for preoperative evaluation, medical device design, hemodynamic simulation and 
medical education, it is also likely to reduce operative risk and increase operative success. However, the 
most relevant studies are case reports or series which are underpowered in testing its actual effect on 
patient outcomes. The decision of making a 3D cardiac model may seem arbitrary since it is mostly 
based on a cardiologist’s perceived difficulty in performing an interventional procedure. A uniform 
consensus is urgently necessary to standardize the key steps of 3D printing from imaging acquisition 
to final production. In the future, more clinical trials of rigorous design are possible to further validate 
the effect of 3D printing on the treatment of cardiovascular diseases. (Cardiol J 2017; 24, 4: 436–444)
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Introduction
Three-dimensional (3D) printing (rapid pro-
totyping, additive manufacturing) is a technology 
which manufactures a 3D object with a prede-
signed, computerized model commonly in a layer-
by-layer manner [1]. Medical 3D printing consists 
mainly of the following steps: image acquisition, 
virtual reconstruction and 3D manufacturing [2]. 
In most cases, virtual models are reconstructed 
from a series of medical images acquired through 
computed tomography (CT), magnetic resonance 
imaging (MRI) or 3D echocardiography. 3D print-
ing has been greatly developed in recent years 
by clinicians as a visualized aid for preoperative 
planning of orthopedic surgery, plastic surgery, and 
oncological surgery among other procedures [3]. 
Some clinicians have also used it for intraoperative 
orientation, postoperative follow-up, device design, 
hemodynamic simulation and medical education 
[4–7]. Up until recently it was unsure whether 
this new technique is merely a gizmo and would 
fade into the past as yet more scientific hype (as 
some sceptics have claimed) or whether it would 
actually prove to be clinically usefull. The develop-
ments in the most recent years indicate it might be 
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worthwhile to further pursue the path. At this point 
is seems to be a true hope for future advances in 
medicine. The exponential growth in the number of 
publications in the field as pictured by the PubMed 
trend (Fig. 1) confirms an increasing interest in 3D 
printing by the scientific community. 
Here we systematically review the current 
applications of 3D printing with regard to cardio-
vascular diseases (CVD), and highlight several 
challenges to be addressed in the future, based 
on a systematic search of the Medline database 
via PubMed on September 30, 2016 using search 
strategies listed in Supplement 1 (see journal 
website, supplementary file). All retrieved 
abstracts were first screened to exclude cell/ani-
mal studies and duplication publications, and full 
articles were further downloaded and examined 
to include studies on the utilities of 3D printing 
in CVD. Primarily a total of 322 articles were 
searched, and a total of 59 articles were finally 
included in this review. 
Current applications of  
3D printing to CVD
Table 1 summarizes the applications of 3D 
printing to operative evaluation, device design and 
hemodynamic simulation of CVD, based on the 
studies of more than 4 cases. Table 2 is a summary 
of studies reporting fewer cases. 
Preoperative, intraoperative  
and postoperative evaluations
In 2006, Ngan et al. [8] generated 3D printing 
models for the preoperative planning of 6 patients 
with pulmonary atresia, ventricular septal defect 
(VSD) and major aortopulmonary collateral arter-
ies. They found that 3D models accurately showed 
96% of major aortopulmonary collateral arteries 
when compared with findings during surgery. How-
ever, their 3D printing models were rigid and thus 
unable to represent the flexibility and motility of 
a real human heart. Soon Noecker et al. [9] created 
several cardiac models using polyurethane mate-
rials. Their cardiac models could be compressed 
using the fingers, representing the first attempt 
at making a flexible model. However, both stud-
ies employed CT which is invasive for patients 
when acquiring raw data for 3D printing. In 2007, 
Schievano et al. [10] and Armillotta et al. [11] used 
MRI datasets to print several right ventricular 
outflow tract models for preoperative guidance of 
percutaneous pulmonary valve implantation. 3D 
echocardiography was first used for 3D printing in 
2014. Mahmood et al. [12] produced mitral valve 
annuli with 3D transesophageal echocardiography 
Figure 1. PubMed trends showing an increasing number of indexed publications on three-dimensional (3D) printing 
AND/NOT heart (any field).
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cardiac models for VSD repair in 35 cases with 
tetralogy of Fallot. Like Ngan et al. [8], they 
observed that the defect sizes were consistent 
between preoperative models and intraoperative 
measurements. 3D-printed cardiac model has 
also been applied to the postoperative evalua-
tion of an atrial septal defect case in uncovering 
potential complications [5]. 
(TEE) datasets. Their study is a landmark for 3D 
printing of CVD because 3D TEE is much more 
frequently used in routine clinical practice when 
compared with CT and MRI. 3D-prined left atrial 
appendage models generated from 3D TEE have 
been recently used to optimize occluder selec-
tion preoperatively [13, 14]. Last year, Ma et 
al. [4] reported the largest study of 3D-printed 
Table 1. Summary of the applications of three dimensional printing to cardiovascular diseases based 
on the studies of ≥ 5 cases.







Ngan EM, 2006 [8] 6 CT Pulmonary atresia, VSD, MAPCA
Noecker AM, 2006 [9] 11 CT Double arch with bilateral type B inter- 
ruption, RAA, aberrant LSCA, Kommerell’s 
diverticulum, TOF, anomalous RCA from 
LCA, anomalous LCA from RCA, peripheral 
pulmonic stenosis, aortic coarctation,  
normal cases
Schievano S, 2007 [10, 11] 12 MRI TOF, homograft conduit, homograft  
monocusp patch, transannular patch
Mahmood F, 2014 [12] 5 3D TEE Ischemic MR, myxomatous valve disease
Koleilat I, 2015 [38] 7 CT Juxtarenal, pararenal, or suprarenal  
abdominal aortic aneurysm
Schmauss D, 2015 [37] 8 CT, MRI Left retro-oesophageal abnormal  
subclavian artery and right descending  
aorta, subpulmonary VSD, hypoplastic  
left heart syndrome, pulmonary atresia,  
hypoplastic right ventricle, AS, primary  
right ventricular tumor, frontolateral  
pseudoaneurysm, severe AVS
Anwar S, 2016 [28] 9 CT, MRI Circumflex distal arch, TOF + pulmonary 
atresia + major aortopulmonary collaterals, 
anomalous pulmonary venous return,  
dextrocardia + DORV + l-TGA, ASD + 
DORV + VSD + d-TGA + severe valvar PS,  
superoinferior ventricles + ASD + VSD,  
heterotaxy syndrome + single ventricle
Liu P, 2016 [13] 8 3D TEE Persistent atrial fibrillation
Garekar S, 2016 [39] 6 CT, MRI DORV, VSD
Ripley B, 2016 [40] 16 CT Paravalvular aortic regurgitation
Ma XJ, 2015 [4] 35 MSCT TOF
Device  
design
Park CY, 1997 [15] 9 MRI Cardiomyopathy
Pepper J, 2013 [6] 34 MRI or CT 
+ CAD
Marfan aortic root
Kurenov SN, 2015 [18] 10 CT Pulmonary artery
Hemodynamic  
simulation
Maragiannis D, 2015 [7]    8 CT, CAD Severe AVS
AS — aortic stenosis; ASD — atrial septal defect; AVS — aortic valve stenosis; MR — mitral regurgitation; MRI  —  magnetic resonance imag-
ing; 3D TEE — three-dimensional transesophageal echocardiography; CT — computed tomography; MSCT — multi-slice computed tomogra-
phy; CAD — computer-aided design; d-TGA — d-transposition of the great arteries; I-TGA — I-transposition of the great arteries; DORV —  
double outlet right ventricle; PS — pulmonary stenosis, MAPCA — major aortopulmonary collateral arteries; RAA — right aortic arch;  
LSCA — left subclavian artery; RCA — right coronary artery; LCA — left coronary artery; VSD — ventricular septal defect; MV — mitral valve; 
TOF — tetralogy of Fallot
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Device development 
Although 3D printing is mostly used for preop-
erative evaluation at present, the first study of 3D 
printing of CVD is about medical device develop-
ment [15]. In 1997, Park et al. [15] designed and 
printed ventricular chambers for totally implantable 
artificial hearts. Their seminal study demonstrated 
for the first time the potential of 3D printing 
in designing patient-specific medical devices. 
Nowadays, a medical device has to be tested by 
numerous animal experiments and various phases 
of clinical trials before it is finally applied to clini-
cal practice [16]. 3D printing is likely to give us 
a new chance to simplify the current workflow of 
device development by allowing patient-specific 
device design. Schievano et al. [17] employed a 3D-
printed pulmonary trunk model to design a novel 
implantable pulmonary valve. Thirty-four external 
supports of Marfan aortic root were also designed 
and printed [6]. Pulmonary artery catheters were 
designed for regional lung chemotherapy [18]. Last 
year, the Food and Drug Administration (FDA) of 
the United States released the first regulation on 
3D printing medical devices, in which 3D print-
ing devices are categorized as Class II because it 
generally does not raise any new safety issues or 
effectiveness issues [19]. 
Hemodynamic simulation
Patients with valvular heart diseases have 
impaired hemodynamics, but it is unfeasible to 
isolate the effects of valve geometry on valvular 
function [20]. 3D-printed heart valves allow in vitro 
hemodynamic simulation [20]. Maragiannis et al. 
[7] used 8 severe aortic valve stenosis models to 
replicate the unique functional characteristics of 
the patients. Their models were likely to aid in the 
refined quantification of aortic root flow and aortic 
stenosis severity. These studies of hemodynamic 
simulation exemplify a new solution to mimic the 
in-vivo characteristics of the human body in an 
in-vitro manner. 
Medical education
Complex structural heart diseases may not be 
easily comprehended by inexperienced cardiolo-
gists and medical students when only two-dimen-
sional pictures are provided. 3D-printed cardiac 
models generated from the medical images of real 
patients are likely to reduce misinterpretations 
of pathological structures. Costello et al. [21, 22] 
printed various VSD models to teach 52 medical 
students and found a significant improvement in 
structural conceptualization. 3D-printed cardiac 
models improve the spatial orientation of medical 
students [23]. However, nurses appear to benefit 
more from model-guided education when compared 
with medical students [24]. As the difficulties of 
obtaining cadavers markedly increase in recent 
years, 3D printing may play an important role in 
anatomical education. Apart from the fact that it 
does not bring about ethical issues [25]. Lim et 
al. [26] it was also found that 3D-printed cardiac 
models are as effective as cadaveric materials for 
medical education. 
Several challenges to be addressed  
in the future
Although 3D printing is likely to serve as 
a useful tool for clinical practice and medical edu-
cation, some doubts have been raised [27]. Here 
Table 2. Summary of applications of three-dimensional printing for cardiovascular diseases based on 
the studies of ≤ 4 cases.
Imaging techniques Diseases
3D TTE/TEE Left atrial appendage occlusion [14], postoperative hemodynamic testing following 
MitraClip procedure [41] 
MRI TGA, VSD, PS [42], DORV [43], hypoplastic aortic arch [44], aortic arch aneurysm [45], 
pulmonary atresia, ASD, tricuspid regurgitation, dextrocardia [46], retroesophageal 
LSA + right aortic arch [47]
MSCT ASD [48, 49], VSD [50], LAA occlusion [51], severe AS [52], extensive AA [53], severe 
mitral valve regurgitation [54], neopulmonary stenosis [55], primary dilated cardiomy-
opathy [56], primary cardiac schwannoma [57], double-chambered right ventricle [58], 
severe pulmonary venous stenosis [59], complex aortic obstruction [60], juxtarenal AA 
[61], DOLV, VSD, PS [62], left atrium osteosarcoma [63], hypertrophic cardiomyopathy 
[64], prosthetic MV perivalvular leak [65], ventricular aneurysm [66], pulmonary venous 
baffle to the systemic right ventricle [67], tricuspid atresia [67], His bundle pacing [68]  
AA — atherosclerotic aneurysm; rest abbreviations are the same with the Table 1
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three challenges are  discussed which need to be 
addressed in the future.
How do we define the indications for  
3D printing of cardiovascular models?
This question is inevitably the first to be an-
swered by a cardiologist who wants to manufacture 
a cardiac model, but currently no guidelines are 
available for reference. Consequently, the decision 
of printing a cardiovascular model is based on its 
structural complexity. Unfortunately, scientific 
standards have not been developed to quantify 
the complexity of cardiovascular structures. It is 
not uncommon to see that when one cardiologist 
manufactures a 3D model of pulmonary stenosis 
[11], another cardiologist manufactures a 3D model 
of pulmonary stenosis, atrial septal defect, double 
outlet right ventricle, ventricular septal defect and 
d-transposition of the great arteries [28]. Many 
studies are case reports of rare diseases without 
control groups. They are underpowered in draw-
ing from a robust conclusion on the efficacy of 3D 
printing for CVD. The indications for 3D printing 
may be resolved in the future by developing an 
expert consensus or guideline. 
Still an experiment
One must bear in mind that 3D printing in medi-
cine can be only applied purely on scientific grounds 
with all its limitations and restraints. Lacking is 
large scale evidence proving its clinical feasibility 
and safety. Thus, apart from ethical board approval, 
it must be considered whether the patient himself 
should consent on taking part in a medical experi-
ment featuring printing of a model and its further 
use for decision making, even if no additional imag-
ing is done (using already available imagery). It is 
concievable that a poorly made model may result in 
easily mislead clinical decisions giving rise to medi-
cal errors, just as a good model may aid in processes 
which lead to better patient outcomes.
Also, the legal status of models are unresolved. 
Is a basic model used to study a specific patient’s 
anatomy just another form of medical documentation 
representing a new way to display medical imigary? 
Is a treatment simulation model a medical device 
or still a medical documentation? These and other 
similar ethical and legal issues remain to be resolved.
Can a static cardiac model represent  
a real dynamic heart?
Image acquisition is the first step of medical 3D 
printing, but it generally captures a specific moment 
of cardiac cycle either at systole or diastole. Thus, 3D 
printing is incapable of reproducing the flexibility and 
mobility of a human heart. In 2007, Markert et al. [29] 
printed a cardiac model inflated with air. Their proof-
of-concept study is an inspiring step to manufacture 
a dynamic heart. Nevertheless, thereafter no similar 
studies have been conducted.
Moreover, the lack of a standard protocol for 
image acquisition and postprocessing undermines 
the quality of 3D-printed models. Motion arti-
facts introduced during image acquisition affects 
the subsequent extraction of region of interest 
[30]. It is challenging to separate cardiac tissues 
from the adjacent tissues of similar Hounsfield 
units. Image postprocessing greatly relies on the 
anatomical knowledge of clinical experts. Without 
image postprocessing, the quality of  a 3D-printed 
model is poor [31]. A new method called blood 
pool segmentation has been recently proposed to 
more accurately extract the region of interest for 
3D printing [32]. Integration of multiple imaging 
modalities may be a good solution in acquiring 
high-quality medical images. A combination of 
multi-slice CT (MSCT) and 3D TEE produces 
a more ideal model compared with MSCT alone [33, 
34]. Fujita et al. [35] developed a preoperative algo-
rithm encompassing chest X-ray, echocardiography 
and 3D printing for the preoperative evaluation of 
congenital heart diseases. Although the algorithm 
minimizes potential misunderstandings of cardiac 
anomalies, it also brings unnecessary imaging 
examinations and additional costs. In addition, the 
more we postprocess medical images, the more 
we may stray from the real anatomical structures. 
A balance between two-dimensional images and 3D 
models should be carefully achieved by those who 
want to use a printed a model. 
How can we make a cost-effective analysis 
before printing a model?
Currently, in routine clinical practice, tran-
sthoracic echocardiography/transesophageal echo-
cardiography, CT and MRI are sufficient to perform 
most procedures, even in challenging cases [36]. 
3D printing is more cost-effective for challeng-
ing cases rather than routine cases. The cost and 
time of manufacturing a 3D model vary between 
$100–450 and 30 min–107 h, respectively, depend-
ing on the size and materials of the model [12, 
18, 37]. To print a 3D model, a cardiologist has to 
buy at least a 3D printer and the raw materials. 
Specialised, proprietary software streamlines the 
image postprocessing and segmentation further 
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increasing the upfront expenses. Another way 
of manufacturing a 3D model is outsourcing the 
imaging postprocessing and 3D manufacturing 
tasks to an industrial company [2]. Either way, not 
all patients can afford this at present. 3D printing 
is also time-consuming. Virtual reconstruction 
generally comprises multiple steps including 
thresholding, region growing, mask calculation, 
model smoothing, and so on (Fig. 2). During the 
final manufacturing process, a model is commonly 
printed in a layer-by-layer manner with the thick-
ness of usually 0.1–1 mm (Video Appendix 1 
— see journal website, supplementary file). 
Although CT is currently the most common imag-
ing modality for 3D printing, it brings radiation 
exposure and additional medical expenditure to 
the patient. Therefore, many factors may affect 
the clinical decision to make a 3D model. Before 
printing a cardiac model, a cardiologist should 
consider a cost–effectiveness analysis to minimize 
the potential harm while maximizing the potential 
benefits of 3D printing for the patient.
Future standard of care?
If at any point in the future printing of medical 
3D models is to become the standard of care (in 
selected cases) it will not only need to become sim-
pler and less time consuming but most importantly 
it will not only need to gather enough scientific 
evidence of clinical safety and usefulness to suc-
cessfully undergo FDA (and its country specific 
counterpart) certification. It will also need to prove 
to be cost-efficient to be covered by the health in-
surance. Despite the fact that in the nearest future 
3D-printed heart models are currently deemed to 
be confined to the walls of the university hospitals, 
as its best suited to aid in finding solutions to the 
most complex cases, one cannot expect widespread 
use without proper reimbursement of the procedure.
Conclusions
Nearly two decades have passed since the first 
report of 3D printing in cardiology. 3D printing 
has been developed for different purposes includ-
Figure 2. Summary of the three-dimensional (3D) printing process. One should notice that the patient and his clini-
cal problem should be at the center of attention at every step. A. Imaging data aqusition; B. Image segmentation; 
C. Surface rendering, virtual model inspection, smoothing and retouching; D. Printing preparation and planning — 
gray represents the supportive material; E. Model additive manufacturing (3D printing) using fused deposition model-
ling technique; F. Final model after removing supportive material.
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ing preoperative evaluation, device development, 
hemodynamic simulation and medical education. 
The majority of studies are case reports which 
are insufficient in drawing a robust conclusion on 
the efficacy of 3D printing for CVD. More studies 
of rigorous design are needed to validate its effect 
on an ever changing clinical practice.  
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